Where Does Tarsus Pharmaceuticals Inc (TARS) Stock Fall in the Biotechnology Field After It Is Down -22.37% This Week?

The 59 rating InvestorsObserver gives to Tarsus Pharmaceuticals Inc (TARS) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 80 percent of stocks in the Biotechnology industry, TARS’s 59 overall rating means the stock scores better than 59 percent of all stocks.

TARS has an Overall Score of 59. Find out what this means to you and get the rest of the rankings on TARS!

See Full TARS Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 59 means the stock is more attractive than 59 percent of stocks. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Tarsus Pharmaceuticals Inc Stock Today?

Tarsus Pharmaceuticals Inc (TARS) stock is trading at $13.64 as of 1:36 PM on Friday, Oct 13, a loss of -$1.45, or -9.64% from the previous closing price of $15.09. The stock has traded between $12.84 and $15.11 so far today. Volume today is high. So far 610,246 shares have traded compared to average volume of 418,757 shares. Click Here to get the full Stock Report for Tarsus Pharmaceuticals Inc stock.